Elanco Animal Health Incorporated
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-232.0M | $338.0M | $-1.23B | $-78.0M | $-483.0M | $-574.0M | $68.0M | $86.5M |
| Depreciation & Amortization | $680.0M | $662.0M | $694.0M | $682.0M | $716.0M | $517.0M | $314.0M | $296.0M |
| Depreciation | — | $95.0M | $92.0M | $89.0M | $108.0M | $122.0M | $94.0M | $81.3M |
| Amortization | $543.0M | $527.0M | $548.0M | $528.0M | $556.0M | $360.0M | $200.0M | $197.4M |
| Stock-Based Compensation | $68.0M | $55.0M | $46.0M | $59.0M | $66.0M | $47.0M | $49.0M | $26.0M |
| Net Cash from Operating Activities | $560.0M | $541.0M | $271.0M | $452.0M | $483.0M | $-41.0M | $224.0M | $487.3M |
| Investing Activities | ||||||||
| Capital Expenditures | $276.0M | $147.0M | $140.0M | $171.0M | $159.0M | $135.0M | $140.0M | $134.5M |
| Business Acquisitions | $0 | $41.0M | $19.0M | $0 | $342.0M | $5.00B | $33.0M | $0 |
| Net Cash from Investing Activities | $-279.0M | $1.16B | $-169.0M | $-179.0M | $-530.0M | $-4.78B | $-235.0M | $-127.0M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-275.0M | $-1.49B | $-83.0M | $-549.0M | $210.0M | $4.95B | $-305.0M | $-35.2M |
| Net Change in Cash | $77.0M | $116.0M | $7.0M | $-293.0M | $132.0M | $161.0M | $-333.0M | $354.1M |
| Free Cash Flow | $284.0M | $394.0M | $131.0M | $281.0M | $324.0M | $-176.0M | $84.0M | $352.8M |